Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating that access to the study record is blocked. The UI includes a 403 header and a Home button, signaling an access restriction rather than study content.
    Difference
    17%
    Check dated 2026-09-20T00:57:57.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 52621 was added as a recruitment site, and Qiryat Krinitzi, Israel, 52621 was removed.
    Difference
    0.0%
    Check dated 2026-09-13T00:10:56.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Israel-based enrollment site Tel Litwinsky, 52621 was removed and a new site, Qiryat Krinitzi, 52621, Israel, was added to the study's location list. This reflects an update to the listed trial sites in Israel, changing where participants in that country can enroll.
    Difference
    0.0%
    Check dated 2026-09-05T22:58:17.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    NIH grant/contract attributions for 2023 and 2014 were added to the study record, and the revision tag was updated to v3.6.6, reflecting a metadata update.
    Difference
    0.2%
    Check dated 2026-08-29T20:00:35.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, signaling a small update to the page's version or content.
    Difference
    0.0%
    Check dated 2026-08-08T23:19:14.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The revision of the page was updated from v3.6.3 to v3.6.4, indicating a small patch to the document's revision metadata.
    Difference
    0.0%
    Check dated 2026-07-25T12:49:54.000Z thumbnail image

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.